AtonRa Partners’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-26,315
| Closed | -$371K | – | 115 |
|
|
2022
Q2 | $371K | Buy |
+26,315
| New | +$371K | 0.34% | 114 |
|
|
2021
Q3 | – | Sell |
-53,527
| Closed | -$1.31M | – | 116 |
|
|
2021
Q2 | $1.31M | Buy |
53,527
+5,373
| +11% | +$131K | 0.48% | 77 |
|
|
2021
Q1 | $1.24M | Sell |
48,154
-7,509
| -13% | -$194K | 0.55% | 74 |
|
|
2020
Q4 | $2.98M | Buy |
+55,663
| New | +$2.98M | 1.46% | 21 |
|